Want to join the conversation?
Chris O'Cull of KeyBanc asks about the G&A guidance change. CEO Todd Penegor said $WEN originally guided to approx. $235MM of G&A. $WEN has to take incentive accruals up greater than 100%. So throughout the year, the company has to fund up for above-plan performance in incentive accruals and also in 1Q16, there were some unusual items.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?